Patrys
Manufacturing · Australia · 1-10 Employees
View Company Info for Free
Overview
Headquarters
L 4 100 Albert Rd, South Melbourne, Vict...Phone Number
(973) 714-6611Website
www.patrys.comRevenue
<$5 MillionStock Symbol
PABIndustry
About Patrys
Patrys Limited is a publicly-listed company dedicated to developing innovative antibody technologies aimed at treating hard-to-treat cancers and addressing acute delirium. The company is advancing a proprietary IV formulation of quetiapine for delirium, targeting patients in postoperative, intensive care, and palliative care settings. Additionally, Patrys is in the early stages of developing a versatile antibody platform, known as deoxymabs, which focuses on NETosis related to cancer and various inflammatory diseases. Their primary clients include patients suffering from these conditions and stakeholders interested in therapeutic advancements.Explore more
SIC Code 28,283NAICS Code 32,325Ticker ASX: PABShow morePatrys Org Chart
Compare Similar Companies to Patrys
Compare insights from companies similar to Patrys, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Patrys Tech Stack
A closer look at the technologies used by Patrys
Top Manufacturing Companies
Top companies in New Zealand by revenue
Top companies in United Kingdom by revenue
Frequently Asked Questions Regarding Patrys
Sign Up For FreeTo access detailed company insights
Patrys Limited is a publicly-listed company dedicated to developing innovative antibody technologies aimed at treating hard-to-treat cancers and addressing acute delirium. The company is advancing a proprietary IV formulation of quetiapine for delirium, targeting patients in postoperative, intensive care, and palliative care settings. Additionally,... Read More